EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Extracellular Vesicles as Orchestrators of Osteoimmunomodulation in Peri‐Implantitis: Implications for Bone Regeneration

Marco Bonilla iD, María Carretero-Fernández, Juan Sainz, Francisco Mesa

Clinical Implant Dentistry and Related Research · 2026-04 · 28 (2)

DOI: 10.1111/cid.70151 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Implant Dentistry and Related Research, online erschienen am 22.04.2026. Verfasst von Marco Bonilla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontics, School of Dentistry, University of Granada, Granada, Spain. Hauptthemen laut MEDLINE: Peri-Implantitis, Bone Regeneration, Extracellular Vesicles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universidad de Granada/CBUA, Universidad de Granada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Peri‐implantitis, characterized by inflammatory bone loss, is a leading cause of dental implant failure. Current regenerative strategies face limitations due to the persistent inflammatory microenvironment. Mesenchymal stem cell‐derived extracellular vesicles (MSC‐EVs) have emerged as promising acellular therapeutics with dual osteogenic and immunomodulatory capacities, offering a novel approach to address the complexity of peri‐implant bone defects.

Methods

This narrative review synthesizes preclinical evidence on MSC‐EVs for peri‐implant bone regeneration. It examines methods for EV isolation from various sources. Furthermore, it analyzes advanced engineered delivery systems, such as peptide‐functionalized implant surfaces and bioactive scaffolds, designed to enhance local retention and therapeutic efficacy.

Results

MSC‐EVs orchestrate bone regeneration through multifaceted mechanisms. They directly stimulate osteogenesis by transferring pro‐osteogenic miRNAs and proteins, activating key pathways like PI3K/AKT and Wnt/β‐catenin. Crucially, they modulate the osteoimmune environment by reprogramming macrophages toward a reparative M2 phenotype, suppressing pro‐inflammatory Th1/Th17 responses, and expanding regulatory T cells (Tregs). Concurrently, MSC‐EVs inhibit bone resorption by favorably modulating the RANKL/OPG balance and directly interfering with osteoclast differentiation. They also promote neovascularization, a critical factor for healing in ischemic zones. Preclinical models demonstrate that localized delivery via engineered systems significantly enhances osseointegration, bone‐implant contact, and regeneration of functional bone‐vessel units.

Conclusion

MSC‐EVs represent a promising and multifaceted therapeutic strategy for bone regeneration in peri‐implantitis, simultaneously targeting inflammation, bone resorption, and osteogenesis. While robust preclinical evidence supports their role in halting bone loss and promoting structured regeneration, successful clinical translation requires further standardization, optimization of delivery, and validation in human trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peri-ImplantitisBone RegenerationExtracellular VesiclesHumansMesenchymal Stem CellsAnimalsOsteogenesis

Stichwörter der Autor:innen

bone regenerationextracellular vesiclesosseointegrationperi‐implantitis

Autor:innen und Institutionen

  • Department of Periodontics, School of Dentistry, University of Granada, Granada, Spain.
  • Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Instituto de Investigación Biosanitaria IBs, Granada, Spain.
  • Department of Biochemistry and Molecular Biology I, Faculty of Sciences, University of Granada, Granada, Spain.
  • Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), University of Barcelona, Barcelona, Spain.

ORCID-Profile: Marco Bonilla

Förderung

  • Universidad de Granada/CBUA
  • Universidad de Granada

Zitieren

APA

Bonilla, M., Carretero-Fernández, M., Sainz, J., & Mesa, F. (2026). Extracellular Vesicles as Orchestrators of Osteoimmunomodulation in Peri‐Implantitis: Implications for Bone Regeneration. Clinical Implant Dentistry and Related Research, 28(2). https://doi.org/10.1111/cid.70151

Vancouver

Bonilla M, Carretero-Fernández M, Sainz J, Mesa F. Extracellular Vesicles as Orchestrators of Osteoimmunomodulation in Peri‐Implantitis: Implications for Bone Regeneration. Clinical Implant Dentistry and Related Research. 2026;28(2). doi:10.1111/cid.70151

BibTeX
@article{Bonilla2026,
  author = {Bonilla, Marco and Carretero-Fernández, María and Sainz, Juan and Mesa, Francisco},
  title = {Extracellular Vesicles as Orchestrators of Osteoimmunomodulation in Peri‐Implantitis: Implications for Bone Regeneration},
  journal = {Clinical Implant Dentistry and Related Research},
  year = {2026},
  volume = {28},
  number = {2},
  doi = {10.1111/cid.70151}
}
Kostenlos starten →